ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Completed · Phase 2 · Has a placebo group

Conditions studied: NASH, MASH, Metabolic Dysfunction-Associated Steatohepatitis, Nonalcoholic Steatohepatitis

In brief

This is a Phase 2a study to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of oral (PO) daily (QD) doses of ALG-055009 (soft gelatin \[softgel\] capsule) for 12 weeks.

Key facts

Study ID

NCT06342947

Run by

Aligos Therapeutics

People needed

102

Starts

2024-04-01

Expected to finish

2024-09-09

Last updated by the study team

2025-02-17

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Aligos Clinical Study Site 18 — Chandler, Arizona, United States
• Aligos Clinical Study Site 15 — Peoria, Arizona, United States
• Aligos Clinical Study Site 17 — Tucson, Arizona, United States
• Aligos Clinical Study Site 35 — Chula Vista, California, United States
• Aligos Clinical Study Site 1 — Lincoln, California, United States
• Aligos Clinical Study Site 37 — Poway, California, United States
• Aligos Clinical Study Site 10 — Rialto, California, United States
• Aligos Clinical Study Site 26 — Bradenton, Florida, United States
• Aligos Clinical Study Site 25 — Clearwater, Florida, United States
• Aligos Clinical Study Site 39 — Fort Myers, Florida, United States
• Aligos Clinical Study Site 2 — Maitland, Florida, United States
• Aligos Clinical Study Site 22 — Ocoee, Florida, United States
• Aligos Clinical Study Site 32 — Port Orange, Florida, United States
• Aligos Clinical Study Site 38 — Sarasota, Florida, United States
• Aligos Clinical Study Site 31 — The Villages, Florida, United States
• Aligos Clinical Study Site 3 — Viera, Florida, United States
• Aligos Clinical Study Site 30 — Winter Park, Florida, United States
• Aligos Clinical Study Site 23 — Athens, Georgia, United States
• Aligos Clinical Study Site 12 — Topeka, Kansas, United States
• Aligos Clinical Study Site 29 — Louisville, Kentucky, United States
• Aligos Clinical Study Site 24 — Bastrop, Louisiana, United States
• Aligos Clinical Study Site 5 — Houma, Louisiana, United States
• Aligos Clinical Study Site 4 — Marrero, Louisiana, United States
• Aligos Clinical Study Site 6 — Metairie, Louisiana, United States
• Aligos Clinical Study Site 14 — Chesterfield, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.